Simile announced a $200M Series B funding round at a $2B post-money valuation.

Led by Greenoaks and joined by Index Ventures, Hanabi Capital, Bain Capital Ventures, CVS Health Ventures, and Definition.

Simile focuses on simulating human behavior to test crucial decisions before execution, used by Fortune 100 companies like CVS Health, Wealthfront, Deloitte, and Gallup.

The company claims 5x revenue growth in five months and significant client acquisition, scaling to over 50 employees worldwide.